Which Cardiovascular Risk Calculator Is Best in Older Adults?
In 2023, the American Heart Association (AHA) introduced a new cardiovascular risk calculator called PREVENT (NEJM JW Gen Med Jul 15 2024 and
Related Articles
Dangers Associated with Raw Milk Remain Clear: Another Outbreak of
Consumption of raw milk and associated products has been linked to various infections; now, public health investigators describe 171 cases of
Better Sites and Methods to Screen for
A major challenge in healthcare settings is screening patients for colonization with Candidozyma auris (formerly Candida auris). To date, screening has
Can We Prevent Transmission of Mitochondrial DNA Disease?
Mitochondrial diseases are caused by mutations in mitochondrial DNA (mtDNA) affecting mitochondrial function. Progressive life-limiting symptoms often
Screening First-Degree Relatives of Patients with Celiac Disease
Nearly all patients with celiac disease have the HLA-DQ2 or DQ8 haplotype. Because of this genetic predisposition, the American College of
Can Ivermectin for Humans Kill Enough Mosquitoes to Diminish Malaria Transmission?
Ivermectin kills mosquitoes that feed on human recipients of the drug. To assess whether mass ivermectin administration can reduce malaria
Optimal Management of NSTEMI in Older Adults: A Meta-Analysis
Deciding whether an older patient should receive invasive or conservative treatment for non–ST-segment elevation myocardial infarction (NSTEMI) is a
Pramipexole as an Adjunct for Treatment-Resistant Depression?
When patients with depression do not respond to antidepressant monotherapy, they are usually prescribed a second antidepressant or an atypical
Does Head Elevation Affect Clinical Status Before Stroke Thrombectomy?
Some patients with acute stroke deteriorate when the head of the bed (HOB) is raised. Lowering the HOB increases residual blood flow and may improve…
Does B-Cell Depletion Work in Generalized Myasthenia Gravis?
B cells are critical to autoantibody generation in myasthenia gravis, but previous trials using rituximab yielded conflicting results. Now, researchers
Tirofiban as Thrombolysis Adjunct for Patients with Acute Ischemic Stroke
Intravenous (IV) thrombolysis with alteplase or tenecteplase is an established treatment for patients with acute ischemic stroke who can be treated